CG Oncology
CGON • NASDAQ
CG Oncology is a biotechnology company in the healthcare sector trading on NASDAQ, led by CEO Arthur Kuan, with a market cap of $5.5B.
Market Cap$5.5B
Employees61.0
CEOArthur Kuan
CountryUnited States of America
Healthcare
Biotechnology
Next EarningsMay 12, 2026 · in a monthQ1 2026
Financials
CG Oncology FAQ
Common questions about CG Oncology
CG Oncology is scheduled to report earnings for Q1 2026 on May 12, 2026. Analysts estimate revenue of $511.8K.
CG Oncology has approximately 61 employees.